Illumina Body Map 2, young vs old
Name | miRBASE accession |
---|---|
hsa-miR-23a-3p
|
MIMAT0000078 |
hsa-miR-23b-3p
|
MIMAT0000418 |
hsa-miR-23c
|
MIMAT0018000 |
hsa-miR-130a-5p
|
MIMAT0004593 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_39197226 | 2.16 |
ENST00000359534.3
|
KCNK5
|
potassium channel, subfamily K, member 5 |
chr7_+_114562172 | 1.44 |
ENST00000393486.1
ENST00000257724.3 |
MDFIC
|
MyoD family inhibitor domain containing |
chr8_+_126442563 | 1.35 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr4_+_154387480 | 1.29 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
chr3_+_30648066 | 1.28 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr4_-_40631859 | 1.22 |
ENST00000295971.7
ENST00000319592.4 |
RBM47
|
RNA binding motif protein 47 |
chr9_-_74383799 | 1.18 |
ENST00000377044.4
|
TMEM2
|
transmembrane protein 2 |
chr5_+_56111361 | 1.15 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr8_+_95653373 | 1.10 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr5_+_40679584 | 1.09 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
chrX_-_129244655 | 0.98 |
ENST00000335997.7
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
chr10_+_89622870 | 0.96 |
ENST00000371953.3
|
PTEN
|
phosphatase and tensin homolog |
chr5_+_82767284 | 0.95 |
ENST00000265077.3
|
VCAN
|
versican |
chr9_+_129622904 | 0.94 |
ENST00000319119.4
|
ZBTB34
|
zinc finger and BTB domain containing 34 |
chr19_+_1026298 | 0.94 |
ENST00000263097.4
|
CNN2
|
calponin 2 |
chr17_+_37026106 | 0.93 |
ENST00000318008.6
|
LASP1
|
LIM and SH3 protein 1 |
chr1_-_205290865 | 0.92 |
ENST00000367157.3
|
NUAK2
|
NUAK family, SNF1-like kinase, 2 |
chr1_-_92351769 | 0.86 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
chr21_-_28338732 | 0.86 |
ENST00000284987.5
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr17_-_46657473 | 0.84 |
ENST00000332503.5
|
HOXB4
|
homeobox B4 |
chr4_-_78740511 | 0.84 |
ENST00000504123.1
ENST00000264903.4 ENST00000515441.1 |
CNOT6L
|
CCR4-NOT transcription complex, subunit 6-like |
chr6_+_89790490 | 0.84 |
ENST00000336032.3
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
chr17_-_10421853 | 0.83 |
ENST00000226207.5
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult |
chr4_-_141677267 | 0.76 |
ENST00000442267.2
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain) |
chr12_+_104324112 | 0.75 |
ENST00000299767.5
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1 |
chr8_+_76452097 | 0.73 |
ENST00000396423.2
|
HNF4G
|
hepatocyte nuclear factor 4, gamma |
chr16_-_89007491 | 0.72 |
ENST00000327483.5
ENST00000564416.1 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr14_+_103058948 | 0.72 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr10_+_72164135 | 0.71 |
ENST00000373218.4
|
EIF4EBP2
|
eukaryotic translation initiation factor 4E binding protein 2 |
chr7_-_139876812 | 0.69 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr1_-_38325256 | 0.67 |
ENST00000373036.4
|
MTF1
|
metal-regulatory transcription factor 1 |
chr6_+_114178512 | 0.66 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chr17_-_40428359 | 0.66 |
ENST00000293328.3
|
STAT5B
|
signal transducer and activator of transcription 5B |
chr3_+_188889737 | 0.65 |
ENST00000345063.3
|
TPRG1
|
tumor protein p63 regulated 1 |
chr14_+_39735411 | 0.64 |
ENST00000603904.1
|
RP11-407N17.3
|
cTAGE family member 5 isoform 4 |
chr3_-_18466787 | 0.63 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
chr15_-_61521495 | 0.62 |
ENST00000335670.6
|
RORA
|
RAR-related orphan receptor A |
chr20_+_13202418 | 0.62 |
ENST00000262487.4
|
ISM1
|
isthmin 1, angiogenesis inhibitor |
chr11_-_96076334 | 0.61 |
ENST00000524717.1
|
MAML2
|
mastermind-like 2 (Drosophila) |
chr5_-_157002775 | 0.61 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr4_-_129208940 | 0.60 |
ENST00000296425.5
|
PGRMC2
|
progesterone receptor membrane component 2 |
chr2_-_172017343 | 0.59 |
ENST00000431350.2
ENST00000360843.3 |
TLK1
|
tousled-like kinase 1 |
chr7_+_69064300 | 0.59 |
ENST00000342771.4
|
AUTS2
|
autism susceptibility candidate 2 |
chr6_-_24721054 | 0.58 |
ENST00000378119.4
|
C6orf62
|
chromosome 6 open reading frame 62 |
chr3_+_152879985 | 0.58 |
ENST00000323534.2
|
RAP2B
|
RAP2B, member of RAS oncogene family |
chrX_+_16804544 | 0.58 |
ENST00000380122.5
ENST00000398155.4 |
TXLNG
|
taxilin gamma |
chr11_+_94277017 | 0.58 |
ENST00000358752.2
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) |
chr4_+_151503077 | 0.57 |
ENST00000317605.4
|
MAB21L2
|
mab-21-like 2 (C. elegans) |
chrX_+_118108571 | 0.56 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
chr17_-_29151794 | 0.55 |
ENST00000324238.6
|
CRLF3
|
cytokine receptor-like factor 3 |
chr5_+_32711419 | 0.55 |
ENST00000265074.8
|
NPR3
|
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
chr8_-_66754172 | 0.54 |
ENST00000401827.3
|
PDE7A
|
phosphodiesterase 7A |
chr17_-_38020392 | 0.54 |
ENST00000346872.3
ENST00000439167.2 ENST00000377945.3 ENST00000394189.2 ENST00000377944.3 ENST00000377958.2 ENST00000535189.1 ENST00000377952.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chr11_+_32914579 | 0.54 |
ENST00000399302.2
|
QSER1
|
glutamine and serine rich 1 |
chr10_-_60027642 | 0.53 |
ENST00000373935.3
|
IPMK
|
inositol polyphosphate multikinase |
chr13_+_73302047 | 0.52 |
ENST00000377814.2
ENST00000377815.3 ENST00000390667.5 |
BORA
|
bora, aurora kinase A activator |
chr20_+_39657454 | 0.51 |
ENST00000361337.2
|
TOP1
|
topoisomerase (DNA) I |
chr22_+_45559722 | 0.51 |
ENST00000347635.4
ENST00000407019.2 ENST00000424634.1 ENST00000417702.1 ENST00000425733.2 ENST00000430547.1 |
NUP50
|
nucleoporin 50kDa |
chr2_-_160472952 | 0.51 |
ENST00000541068.2
ENST00000355831.2 ENST00000343439.5 ENST00000392782.1 |
BAZ2B
|
bromodomain adjacent to zinc finger domain, 2B |
chr10_+_112836779 | 0.51 |
ENST00000280155.2
|
ADRA2A
|
adrenoceptor alpha 2A |
chrX_+_46433193 | 0.51 |
ENST00000276055.3
|
CHST7
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
chr11_+_68080077 | 0.51 |
ENST00000294304.7
|
LRP5
|
low density lipoprotein receptor-related protein 5 |
chr8_-_91658303 | 0.51 |
ENST00000458549.2
|
TMEM64
|
transmembrane protein 64 |
chr1_+_26798955 | 0.50 |
ENST00000361427.5
|
HMGN2
|
high mobility group nucleosomal binding domain 2 |
chr21_+_44394620 | 0.49 |
ENST00000291547.5
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
chr17_-_40761375 | 0.49 |
ENST00000543197.1
ENST00000309428.5 |
FAM134C
|
family with sequence similarity 134, member C |
chr11_-_130184555 | 0.49 |
ENST00000525842.1
|
ZBTB44
|
zinc finger and BTB domain containing 44 |
chr6_-_82462425 | 0.48 |
ENST00000369754.3
ENST00000320172.6 ENST00000369756.3 |
FAM46A
|
family with sequence similarity 46, member A |
chr17_+_1958388 | 0.48 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
chr2_-_208634287 | 0.48 |
ENST00000295417.3
|
FZD5
|
frizzled family receptor 5 |
chr12_+_122242597 | 0.48 |
ENST00000267197.5
|
SETD1B
|
SET domain containing 1B |
chr1_+_24286287 | 0.47 |
ENST00000334351.7
ENST00000374468.1 |
PNRC2
|
proline-rich nuclear receptor coactivator 2 |
chr6_+_106546808 | 0.47 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr1_+_107599267 | 0.47 |
ENST00000361318.5
ENST00000370078.1 |
PRMT6
|
protein arginine methyltransferase 6 |
chr2_+_139259324 | 0.47 |
ENST00000280098.4
|
SPOPL
|
speckle-type POZ protein-like |
chr4_-_23891693 | 0.47 |
ENST00000264867.2
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
chr17_-_10452929 | 0.47 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
chr12_-_10766184 | 0.46 |
ENST00000539554.1
ENST00000381881.2 ENST00000320756.2 |
MAGOHB
|
mago-nashi homolog B (Drosophila) |
chr2_+_176981307 | 0.46 |
ENST00000249501.4
|
HOXD10
|
homeobox D10 |
chr4_-_185395672 | 0.46 |
ENST00000393593.3
|
IRF2
|
interferon regulatory factor 2 |
chr3_-_112218378 | 0.46 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
chr3_-_113465065 | 0.46 |
ENST00000497255.1
ENST00000478020.1 ENST00000240922.3 ENST00000493900.1 |
NAA50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
chrX_-_110513703 | 0.46 |
ENST00000324068.1
|
CAPN6
|
calpain 6 |
chr11_+_14665263 | 0.46 |
ENST00000282096.4
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
chr8_-_141645645 | 0.45 |
ENST00000519980.1
ENST00000220592.5 |
AGO2
|
argonaute RISC catalytic component 2 |
chr13_+_47127293 | 0.45 |
ENST00000311191.6
|
LRCH1
|
leucine-rich repeats and calponin homology (CH) domain containing 1 |
chr4_+_38665810 | 0.45 |
ENST00000261438.5
ENST00000514033.1 |
KLF3
|
Kruppel-like factor 3 (basic) |
chr6_-_16761678 | 0.45 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
chr2_-_158485387 | 0.45 |
ENST00000243349.8
|
ACVR1C
|
activin A receptor, type IC |
chr19_+_45973120 | 0.45 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr9_+_32384617 | 0.45 |
ENST00000379923.1
ENST00000309951.6 ENST00000541043.1 |
ACO1
|
aconitase 1, soluble |
chr3_+_69812877 | 0.44 |
ENST00000457080.1
ENST00000328528.6 |
MITF
|
microphthalmia-associated transcription factor |
chr17_-_56494713 | 0.44 |
ENST00000407977.2
|
RNF43
|
ring finger protein 43 |
chr17_+_75136980 | 0.44 |
ENST00000585618.1
ENST00000413679.2 |
SEC14L1
|
SEC14-like 1 (S. cerevisiae) |
chr8_-_122653630 | 0.43 |
ENST00000303924.4
|
HAS2
|
hyaluronan synthase 2 |
chr12_+_94542459 | 0.43 |
ENST00000258526.4
|
PLXNC1
|
plexin C1 |
chr17_-_27621125 | 0.43 |
ENST00000579665.1
ENST00000225388.4 |
NUFIP2
|
nuclear fragile X mental retardation protein interacting protein 2 |
chr8_-_71316021 | 0.43 |
ENST00000452400.2
|
NCOA2
|
nuclear receptor coactivator 2 |
chr16_-_48644061 | 0.43 |
ENST00000262384.3
|
N4BP1
|
NEDD4 binding protein 1 |
chr7_+_65338230 | 0.43 |
ENST00000360768.3
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr3_-_182698381 | 0.43 |
ENST00000292782.4
|
DCUN1D1
|
DCN1, defective in cullin neddylation 1, domain containing 1 |
chr20_-_31071239 | 0.42 |
ENST00000359676.5
|
C20orf112
|
chromosome 20 open reading frame 112 |
chr10_+_103986085 | 0.41 |
ENST00000370005.3
|
ELOVL3
|
ELOVL fatty acid elongase 3 |
chr5_+_32788945 | 0.41 |
ENST00000326958.1
|
AC026703.1
|
AC026703.1 |
chr11_+_111473108 | 0.41 |
ENST00000304987.3
|
SIK2
|
salt-inducible kinase 2 |
chr4_-_80994210 | 0.41 |
ENST00000403729.2
|
ANTXR2
|
anthrax toxin receptor 2 |
chr10_-_99094458 | 0.41 |
ENST00000371019.2
|
FRAT2
|
frequently rearranged in advanced T-cell lymphomas 2 |
chr3_+_31574189 | 0.40 |
ENST00000295770.2
|
STT3B
|
STT3B, subunit of the oligosaccharyltransferase complex (catalytic) |
chr5_+_162864575 | 0.40 |
ENST00000512163.1
ENST00000393929.1 ENST00000340828.2 ENST00000511683.2 ENST00000510097.1 ENST00000511490.2 ENST00000510664.1 |
CCNG1
|
cyclin G1 |
chr14_-_38064198 | 0.40 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
chr3_-_88108192 | 0.39 |
ENST00000309534.6
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
chr4_-_125633876 | 0.39 |
ENST00000504087.1
ENST00000515641.1 |
ANKRD50
|
ankyrin repeat domain 50 |
chr16_+_24741013 | 0.39 |
ENST00000315183.7
ENST00000395799.3 |
TNRC6A
|
trinucleotide repeat containing 6A |
chr10_+_18098352 | 0.39 |
ENST00000239761.3
|
MRC1
|
mannose receptor, C type 1 |
chr12_+_32655048 | 0.39 |
ENST00000427716.2
ENST00000266482.3 |
FGD4
|
FYVE, RhoGEF and PH domain containing 4 |
chr3_+_196466710 | 0.38 |
ENST00000327134.3
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2 |
chr19_+_41305406 | 0.38 |
ENST00000406058.2
ENST00000593726.1 |
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
chr7_+_138916231 | 0.38 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr16_+_53468332 | 0.37 |
ENST00000262133.6
|
RBL2
|
retinoblastoma-like 2 (p130) |
chr6_+_119215308 | 0.37 |
ENST00000229595.5
|
ASF1A
|
anti-silencing function 1A histone chaperone |
chr21_+_39628655 | 0.37 |
ENST00000398925.1
ENST00000398928.1 ENST00000328656.4 ENST00000443341.1 |
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr3_-_71834318 | 0.37 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
chr4_+_84457250 | 0.36 |
ENST00000395226.2
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr11_-_76091986 | 0.36 |
ENST00000260045.3
|
PRKRIR
|
protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) |
chr17_-_46671323 | 0.36 |
ENST00000239151.5
|
HOXB5
|
homeobox B5 |
chr2_-_201936302 | 0.36 |
ENST00000453765.1
ENST00000452799.1 ENST00000446678.1 ENST00000418596.3 |
FAM126B
|
family with sequence similarity 126, member B |
chr10_+_17851362 | 0.35 |
ENST00000331429.2
ENST00000457317.1 |
MRC1L1
|
cDNA FLJ56855, highly similar to Macrophage mannose receptor 1 |
chr4_+_160188889 | 0.35 |
ENST00000264431.4
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr12_+_104682496 | 0.35 |
ENST00000378070.4
|
TXNRD1
|
thioredoxin reductase 1 |
chr8_-_119124045 | 0.35 |
ENST00000378204.2
|
EXT1
|
exostosin glycosyltransferase 1 |
chr4_+_155665123 | 0.35 |
ENST00000336356.3
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) |
chr12_-_7655329 | 0.35 |
ENST00000541972.1
|
CD163
|
CD163 molecule |
chr9_+_33817461 | 0.34 |
ENST00000263228.3
|
UBE2R2
|
ubiquitin-conjugating enzyme E2R 2 |
chr18_+_3451646 | 0.34 |
ENST00000345133.5
ENST00000330513.5 ENST00000549546.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
chr5_+_149887672 | 0.34 |
ENST00000261797.6
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr10_+_99079008 | 0.34 |
ENST00000371021.3
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas |
chr6_+_45389893 | 0.34 |
ENST00000371432.3
|
RUNX2
|
runt-related transcription factor 2 |
chr6_-_3457256 | 0.33 |
ENST00000436008.2
|
SLC22A23
|
solute carrier family 22, member 23 |
chr10_-_101989315 | 0.33 |
ENST00000370397.7
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase |
chr2_-_209119831 | 0.33 |
ENST00000345146.2
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble |
chr14_-_53162361 | 0.32 |
ENST00000395686.3
|
ERO1L
|
ERO1-like (S. cerevisiae) |
chr1_-_212004090 | 0.32 |
ENST00000366997.4
|
LPGAT1
|
lysophosphatidylglycerol acyltransferase 1 |
chr11_+_113930291 | 0.32 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr3_-_52713729 | 0.32 |
ENST00000296302.7
ENST00000356770.4 ENST00000337303.4 ENST00000409057.1 ENST00000410007.1 ENST00000409114.3 ENST00000409767.1 ENST00000423351.1 |
PBRM1
|
polybromo 1 |
chr10_-_65225722 | 0.32 |
ENST00000399251.1
|
JMJD1C
|
jumonji domain containing 1C |
chr10_+_120967072 | 0.31 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
chr16_-_79634595 | 0.31 |
ENST00000326043.4
ENST00000393350.1 |
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr10_+_121652204 | 0.31 |
ENST00000369075.3
ENST00000543134.1 |
SEC23IP
|
SEC23 interacting protein |
chr2_+_112812778 | 0.31 |
ENST00000283206.4
|
TMEM87B
|
transmembrane protein 87B |
chrX_-_83757399 | 0.31 |
ENST00000373177.2
ENST00000297977.5 ENST00000506585.2 ENST00000449553.2 |
HDX
|
highly divergent homeobox |
chr3_-_87040233 | 0.31 |
ENST00000398399.2
|
VGLL3
|
vestigial like 3 (Drosophila) |
chr1_-_39339777 | 0.30 |
ENST00000397572.2
|
MYCBP
|
MYC binding protein |
chr14_-_68141535 | 0.30 |
ENST00000554659.1
|
VTI1B
|
vesicle transport through interaction with t-SNAREs 1B |
chr20_+_49348081 | 0.30 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
chr1_-_120190396 | 0.30 |
ENST00000421812.2
|
ZNF697
|
zinc finger protein 697 |
chr21_+_35445827 | 0.30 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
chr8_-_103876965 | 0.30 |
ENST00000337198.5
|
AZIN1
|
antizyme inhibitor 1 |
chr19_-_33793430 | 0.30 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr8_-_82024290 | 0.29 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
chr1_+_44115814 | 0.29 |
ENST00000372396.3
|
KDM4A
|
lysine (K)-specific demethylase 4A |
chr2_-_1748214 | 0.29 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr3_+_88188254 | 0.29 |
ENST00000309495.5
|
ZNF654
|
zinc finger protein 654 |
chr2_+_48541776 | 0.29 |
ENST00000413569.1
ENST00000340553.3 |
FOXN2
|
forkhead box N2 |
chr8_+_59465728 | 0.29 |
ENST00000260130.4
ENST00000422546.2 ENST00000447182.2 ENST00000413219.2 ENST00000424270.2 ENST00000523483.1 ENST00000520168.1 |
SDCBP
|
syndecan binding protein (syntenin) |
chr4_-_100575781 | 0.29 |
ENST00000511828.1
|
RP11-766F14.2
|
Protein LOC285556 |
chr7_+_30323923 | 0.29 |
ENST00000323037.4
|
ZNRF2
|
zinc and ring finger 2 |
chr8_-_28243934 | 0.29 |
ENST00000521185.1
ENST00000520290.1 ENST00000344423.5 |
ZNF395
|
zinc finger protein 395 |
chr9_-_16870704 | 0.28 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr5_+_137801160 | 0.28 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
chr20_+_37434329 | 0.28 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
chr4_-_174256276 | 0.28 |
ENST00000296503.5
|
HMGB2
|
high mobility group box 2 |
chr1_-_225615599 | 0.28 |
ENST00000421383.1
ENST00000272163.4 |
LBR
|
lamin B receptor |
chr12_+_107349497 | 0.28 |
ENST00000548125.1
ENST00000280756.4 |
C12orf23
|
chromosome 12 open reading frame 23 |
chr7_+_144052381 | 0.27 |
ENST00000498580.1
ENST00000056217.5 |
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
chr6_+_153019023 | 0.27 |
ENST00000367245.5
ENST00000529453.1 |
MYCT1
|
myc target 1 |
chr10_+_115438920 | 0.27 |
ENST00000429617.1
ENST00000369331.4 |
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr7_-_93633684 | 0.27 |
ENST00000222547.3
ENST00000425626.1 |
BET1
|
Bet1 golgi vesicular membrane trafficking protein |
chr10_+_93683519 | 0.27 |
ENST00000265990.6
|
BTAF1
|
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa |
chr1_-_150669500 | 0.26 |
ENST00000271732.3
|
GOLPH3L
|
golgi phosphoprotein 3-like |
chr8_-_8751068 | 0.26 |
ENST00000276282.6
|
MFHAS1
|
malignant fibrous histiocytoma amplified sequence 1 |
chr15_-_60690163 | 0.26 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
chr1_+_118148556 | 0.26 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
chr1_+_244214577 | 0.26 |
ENST00000358704.4
|
ZBTB18
|
zinc finger and BTB domain containing 18 |
chr5_-_131826457 | 0.26 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
chr8_+_74206829 | 0.26 |
ENST00000240285.5
|
RDH10
|
retinol dehydrogenase 10 (all-trans) |
chr2_-_10952922 | 0.26 |
ENST00000272227.3
|
PDIA6
|
protein disulfide isomerase family A, member 6 |
chr1_-_114355083 | 0.25 |
ENST00000261441.5
|
RSBN1
|
round spermatid basic protein 1 |
chr8_+_61591337 | 0.25 |
ENST00000423902.2
|
CHD7
|
chromodomain helicase DNA binding protein 7 |
chr4_+_129730779 | 0.25 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
chr4_+_15004165 | 0.25 |
ENST00000538197.1
ENST00000541112.1 ENST00000442003.2 |
CPEB2
|
cytoplasmic polyadenylation element binding protein 2 |
chr20_+_62371206 | 0.25 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
chr22_+_40573921 | 0.25 |
ENST00000454349.2
ENST00000335727.9 |
TNRC6B
|
trinucleotide repeat containing 6B |
chr12_+_70636765 | 0.25 |
ENST00000552231.1
ENST00000229195.3 ENST00000547780.1 ENST00000418359.3 |
CNOT2
|
CCR4-NOT transcription complex, subunit 2 |
chr8_+_86376081 | 0.25 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
chr6_+_143929307 | 0.24 |
ENST00000427704.2
ENST00000305766.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
chr6_+_110501344 | 0.24 |
ENST00000368932.1
|
CDC40
|
cell division cycle 40 |
chr6_+_71998506 | 0.24 |
ENST00000370435.4
|
OGFRL1
|
opioid growth factor receptor-like 1 |
chr20_+_3451650 | 0.24 |
ENST00000262919.5
|
ATRN
|
attractin |
chr1_-_245027833 | 0.24 |
ENST00000444376.2
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) |
chr16_+_88493879 | 0.24 |
ENST00000565624.1
ENST00000437464.1 |
ZNF469
|
zinc finger protein 469 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.4 | 1.3 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.4 | 1.1 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.3 | 0.8 | GO:0031247 | actin rod assembly(GO:0031247) |
0.2 | 1.0 | GO:1903984 | negative regulation of ribosome biogenesis(GO:0090071) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.9 | GO:0044691 | tooth eruption(GO:0044691) |
0.2 | 0.6 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.2 | 0.8 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.2 | 0.9 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 0.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.5 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.2 | 0.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.2 | 0.5 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.6 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 1.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.7 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
0.1 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.4 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 2.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.3 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.1 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.5 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.1 | 0.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 0.3 | GO:0052418 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.1 | 0.3 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.1 | 0.3 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.1 | 0.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.2 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.1 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.6 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.0 | 0.1 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.0 | 0.3 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.0 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.6 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.2 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.0 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.2 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.3 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.1 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.0 | 0.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.0 | 1.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.0 | 0.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) B cell costimulation(GO:0031296) |
0.0 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.3 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.2 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.8 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.0 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.0 | 0.1 | GO:0032618 | interleukin-15 production(GO:0032618) |
0.0 | 0.0 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
0.0 | 0.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.0 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0060936 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
0.0 | 0.1 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.2 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.0 | 1.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.7 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.2 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.5 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.0 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.0 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.0 | 0.5 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 1.3 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.1 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.0 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.0 | GO:0061582 | colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 0.0 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.1 | GO:0051292 | nuclear pore organization(GO:0006999) nuclear pore complex assembly(GO:0051292) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.5 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.2 | 0.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 1.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 1.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.2 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.0 | 0.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.0 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 3.0 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.0 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.0 | 0.2 | GO:0072357 | glycogen granule(GO:0042587) PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 2.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 1.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.3 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.3 | 0.9 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.2 | 1.0 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.2 | 0.5 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.2 | 0.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0051538 | iron-responsive element binding(GO:0030350) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 0.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.3 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.3 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.1 | 0.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.3 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 1.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 2.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 1.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.4 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.1 | 0.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.8 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.4 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.0 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.2 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.0 | 0.2 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.0 | 0.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.3 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.1 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.0 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 1.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.0 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.3 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.0 | 0.1 | GO:0035501 | MH2 domain binding(GO:0035500) MH1 domain binding(GO:0035501) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.0 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.0 | 0.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 4.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.0 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 1.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 2.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 1.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |